Advertisement
Review| Volume 85, ISSUE 1, P4-13, July 2009

Cigarette smoking, smoking cessation, and diabetes

      Abstract

      There is evidence for increased risk of developing type 2 diabetes among cigarette smokers. In addition, smoking-associated health risks can exacerbate major conditions that precede or accompany diabetes, such as cardiovascular and kidney diseases. Smoking cessation can result in weight gain and a short-term worsening of some diabetic symptoms that may deter smokers with diabetes from attempting to quit. Additionally, there is limited evidence regarding the efficacy/safety of smoking cessation pharmacotherapies in this population and the general effects of smoking cessation, particularly for type 1 diabetes. Smoking cessation in diabetes therefore remains a highly relevant subject for further research.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Eyre H.
        • Kahn R.
        • Robertson R.M.
        • Clark N.G.
        • Doyle C.
        • Hong Y.
        • et al.
        Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association.
        Circulation. 2004; 109: 3244-3255
        • Mozaffarian D.
        • Marfisi R.
        • Levantesi G.
        • Silletta M.G.
        • Tavazzi L.
        • Tognoni G.
        • et al.
        Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.
        Lancet. 2007; 370: 667-675
        • Solberg L.I.
        • Desai J.R.
        • O’Connor P.J.
        • Bishop D.B.
        • Devlin H.M.
        Diabetic patients who smoke: are they different?.
        Ann. Fam. Med. 2004; 2: 26-32
      1. Centers for Disease Control and Prevention, 2004 Surgeon General's Report—The Health Consequences of Smoking. http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/chapters.htm (accessed 1.05.08).

        • Fiore M.
        • Jaén C.
        • Baker T.
        • Benowitz N.
        • Curry S.
        • Dorfman S.
        • et al.
        Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline.
        Department of Health and Human Services, Public Health Service, Rockville, MD, U.S.May 2008
        • Twardella D.
        • Loew M.
        • Rothenbacher D.
        • Stegmaier C.
        • Ziegler H.
        • Brenner H.
        The diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a retrospective cohort study.
        J. Clin. Epidemiol. 2006; 59: 82-89
        • Wilkes S.
        • Evans A.
        A cross-sectional study comparing the motivation for smoking cessation in apparently healthy patients who smoke to those who smoke and have ischaemic heart disease, hypertension or diabetes.
        Fam. Pract. 1999; 16: 608-610
      2. Centers for Disease Control and Prevention, Diabetes data and trends. http://apps.nccd.cdc.gov/DDTSTRS/default.aspx (accessed 1.05.08).

        • Jenssen T.G.
        • Tonstad S.
        • Claudi T.
        • Midthjell K.
        • Cooper J.
        The gap between guidelines and practice in the treatment of type 2 diabetes. A nationwide survey in Norway.
        Diabetes Res. Clin. Pract. 2008; 80: 314-320
        • Haire-Joshu D.
        • Heady S.
        • Thomas L.
        • Schechtman K.
        • Fisher Jr., E.B.
        Beliefs about smoking and diabetes care.
        Diabetes Educ. 1994; 20: 410-415
        • Wakefield M.
        • Roberts L.
        • Rosenfeld E.
        Prospects for smoking cessation among people with insulin-dependent diabetes.
        Patient Educ. Couns. 1998; 34: 257-266
        • Kawakami N.
        • Takatsuka N.
        • Shimizu H.
        • Ishibashi H.
        Effects of smoking on the incidence of non-insulin-dependent diabetes mellitus. Replication and extension in a Japanese cohort of male employees.
        Am. J. Epidemiol. 1997; 145: 103-109
        • Nakanishi N.
        • Nakamura K.
        • Matsuo Y.
        • Suzuki K.
        • Tatara K.
        Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men.
        Ann. Intern. Med. 2000; 133: 183-191
        • Manson J.E.
        • Ajani U.A.
        • Liu S.
        • Nathan D.M.
        • Hennekens C.H.
        A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians.
        Am. J. Med. 2000; 109: 538-542
        • Wannamethee S.G.
        • Shaper A.G.
        • Perry I.J.
        Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men.
        Diabetes Care. 2001; 24: 1590-1595
        • Willi C.
        • Bodenmann P.
        • Ghali W.A.
        • Faris P.D.
        • Cornuz J.
        Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis.
        JAMA. 2007; 298: 2654-2664
        • Persson P.G.
        • Carlsson S.
        • Svanstrom L.
        • Ostenson C.G.
        • Efendic S.
        • Grill V.
        Cigarette smoking, oral moist snuff use and glucose intolerance.
        J. Intern. Med. 2000; 248: 103-110
        • Lee P.N.
        Circulatory disease and smokeless tobacco in Western populations: a review of the evidence.
        Int. J. Epidemiol. 2007; 36: 789-804
        • Eliasson M.
        • Asplund K.
        • Nasic S.
        • Rodu B.
        Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study.
        J. Intern. Med. 2004; 256: 101-110
        • Janzon L.
        • Berntorp K.
        • Hanson M.
        • Lindell S.E.
        • Trell E.
        Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men.
        Diabetologia. 1983; 25: 86-88
        • Sandberg H.
        • Roman L.
        • Zavodnick J.
        • Kupers N.
        The effect of smoking on serum somatotropin, immunoreactive insulin and blood glucose levels of young adult males.
        J. Pharmacol. Exp. Ther. 1973; 184: 787-791
        • Targher G.
        • Alberiche M.
        • Zenere M.B.
        • Bonadonna R.C.
        • Muggeo M.
        • Bonora E.
        Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus.
        J. Clin. Endocrinol. Metab. 1997; 82: 3619-3624
        • Nilsson P.M.
        • Gudbjornsdottir S.
        • Eliasson B.
        • Cederholm J.
        Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes—data from the National Diabetes Register in Sweden.
        Diabetes Metab. 2004; 30: 261-268
        • Sargeant L.A.
        • Khaw K.T.
        • Bingham S.
        • Day N.E.
        • Luben R.N.
        • Oakes S.
        • et al.
        Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European prospective investigation into cancer.
        Int. J. Epidemiol. 2001; 30: 547-554
        • Kong C.
        • Nimmo L.
        • Elatrozy T.
        • Anyaoku V.
        • Hughes C.
        • Robinson S.
        • et al.
        Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in type 2 diabetes.
        Atherosclerosis. 2001; 156: 373-378
        • Meigs J.B.
        • Singer D.E.
        • Sullivan L.M.
        • Dukes K.A.
        • D’Agostino R.B.
        • Nathan D.M.
        • et al.
        Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team.
        Am. J. Med. 1997; 102: 38-47
        • Eliasson B.
        Cigarette smoking and diabetes.
        Prog. Cardiovasc. Dis. 2003; 45: 405-413
        • Al-Delaimy W.K.
        • Manson J.E.
        • Solomon C.G.
        • Kawachi I.
        • Stampfer M.J.
        • Willett W.C.
        • et al.
        Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus.
        Arch. Intern. Med. 2002; 162: 273-279
        • Stevens R.J.
        • Kothari V.
        • Adler A.I.
        • Stratton I.M.
        The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56).
        Clin. Sci. (London). 2001; 101: 671-679
        • Tuomilehto J.
        • Rastenyte D.
        • Jousilahti P.
        • Sarti C.
        • Vartiainen E.
        Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population.
        Stroke. 1996; 27: 210-215
        • Kothari V.
        • Stevens R.J.
        • Adler A.I.
        • Stratton I.M.
        • Manley S.E.
        • Neil H.A.
        • et al.
        UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
        Stroke. 2002; 33: 1776-1781
        • Yong T.Y.
        • Phillipov G.
        • Phillips P.J.
        Management outcomes of patients with type 2 diabetes: targeting the 10-year absolute risk of coronary heart disease.
        Med. J. Aust. 2007; 186: 622-624
        • Howard B.V.
        • Howard W.J.
        The compelling case for smoking cessation in diabetics.
        Circulation. 1990; 82: 299-301
        • Moy C.S.
        • LaPorte R.E.
        • Dorman J.S.
        • Songer T.J.
        • Orchard T.J.
        • Kuller L.H.
        • et al.
        Insulin-dependent diabetes mellitus mortality. The risk of cigarette smoking.
        Circulation. 1990; 82: 37-43
        • Rossing P.
        • Hougaard P.
        • Borch-Johnsen K.
        • Parving H.H.
        Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
        BMJ. 1996; 313: 779-784
        • Gay E.C.
        • Cai Y.
        • Gale S.M.
        • Baron A.
        • Cruickshanks K.J.
        • Kostraba J.N.
        • et al.
        Smokers with IDDM experience excess morbidity. The Colorado IDDM Registry.
        Diabetes Care. 1992; 15: 947-952
        • Biesenbach G.
        • Grafinger P.
        • Janko O.
        • Zazgornik J.
        Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients.
        Clin. Nephrol. 1997; 48: 146-150
        • Gambaro G.
        • Bax G.
        • Fusaro M.
        • Normanno M.
        • Manani S.M.
        • Zanella M.
        • et al.
        Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus.
        Diabetes, Nutr. Metab. 2001; 14: 337-342
        • Ritz E.
        • Ogata H.
        • Orth S.R.
        Smoking: a factor promoting onset and progression of diabetic nephropathy.
        Diabetes Metab. 2000; 26: 54-63
        • Chuahirun T.
        • Simoni J.
        • Hudson C.
        • Seipel T.
        • Khanna A.
        • Harrist R.B.
        • et al.
        Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.
        Am. J. Med. Sci. 2004; 327: 57-67
        • Krimholtz M.
        • Thomas S.
        • Viberti G.
        Cigarette smoking and diabetic nephropathy.
        Contrib. Nephrol. 2000; 130: 85-93
        • Mitchell B.D.
        • Hawthorne V.M.
        • Vinik A.I.
        Cigarette smoking and neuropathy in diabetic patients.
        Diabetes Care. 1990; 13: 434-437
        • Tamer A.
        • Yildiz S.
        • Yildiz N.
        • Kanat M.
        • Gunduz H.
        • Tahtaci M.
        • et al.
        The prevalence of neuropathy and relationship with risk factors in diabetic patients: a single-center experience.
        Med. Princ. Pract. 2006; 15: 190-194
        • Stratton I.M.
        • Kohner E.M.
        • Aldington S.J.
        • Turner R.C.
        • Holman R.R.
        • Manley S.E.
        • et al.
        UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis.
        Diabetologia. 2001; 44: 156-163
        • Guillausseau P.J.
        • Massin P.
        • Charles M.A.
        • Allaguy H.
        • Guvenli Z.
        • Virally M.
        • et al.
        Glycaemic control and development of retinopathy in type 2 diabetes mellitus: a longitudinal study.
        Diabetes Med. 1998; 15: 151-155
        • Owens D.R.
        • Volund A.
        • Jones D.
        • Shannon A.G.
        • Jones I.R.
        • Birtwell A.J.
        • et al.
        Retinopathy in newly presenting non-insulin-dependent (type 2) diabetic patients.
        Diabetes Res. 1988; 9: 59-65
        • Zoppini G.
        • Targher G.
        • Monauni T.
        • Faccini G.
        • Pasqualini E.
        • Martinelli C.
        • et al.
        Increase in circulating products of lipid peroxidation in smokers with IDDM.
        Diabetes Care. 1996; 19: 1233-1236
        • Sawicki P.T.
        • Didjurgeit U.
        • Muhlhauser I.
        • Bender R.
        • Heinemann L.
        • Berger M.
        Smoking is associated with progression of diabetic nephropathy.
        Diabetes Care. 1994; 17: 126-131
        • Morrow J.D.
        • Frei B.
        • Longmire A.W.
        • Gaziano J.M.
        • Lynch S.M.
        • Shyr Y.
        • et al.
        Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.
        N. Engl. J. Med. 1995; 332: 1198-1203
        • Reilly M.
        • Delanty N.
        • Lawson J.A.
        • FitzGerald G.A.
        Modulation of oxidant stress in vivo in chronic cigarette smokers.
        Circulation. 1996; 94: 19-25
        • Chaturvedi N.
        • Stephenson J.M.
        • Fuller J.H.
        The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study.
        Diabetes Care. 1995; 18: 785-792
        • Hirai F.E.
        • Moss S.E.
        • Klein B.E.
        • Klein R.
        Severe hypoglycemia and smoking in a long-term type 1 diabetic population: Wisconsin Epidemiologic Study of Diabetic Retinopathy.
        Diabetes Care. 2007; 30: 1437-1441
        • Will J.C.
        • Galuska D.A.
        • Ford E.S.
        • Mokdad A.
        • Calle E.E.
        Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study.
        Int. J. Epidemiol. 2001; 30: 540-546
        • Hur N.W.
        • Kim H.C.
        • Nam C.M.
        • Jee S.H.
        • Lee H.C.
        • Suh I.
        Smoking cessation and risk of type 2 diabetes mellitus: Korea Medical Insurance Corporation Study.
        Eur. J. Cardiovasc. Prev. Rehabil. 2007; 14: 244-249
        • Beziaud F.
        • Halimi J.M.
        • Lecomte P.
        • Vol S.
        • Tichet J.
        Cigarette smoking and diabetes mellitus.
        Diabetes Metab. 2004; 30: 161-166
        • Iino K.
        • Iwase M.
        • Tsutsu N.
        • Iida M.
        Smoking cessation and glycaemic control in type 2 diabetic patients.
        Diabetes, Obes. Metab. 2004; 6: 181-186
        • Mikhailidis D.P.
        • Papadakis J.A.
        • Ganotakis E.S.
        Smoking, diabetes and hyperlipidaemia.
        J. R. Soc. Health. 1998; 118: 91-93
        • Becker R.H.
        • Sha S.
        • Frick A.D.
        • Fountaine R.J.
        The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin.
        Diabetes Care. 2006; 29: 277-282
        • Albanes D.
        • Jones D.Y.
        • Micozzi M.S.
        • Mattson M.E.
        Associations between smoking and body weight in the US population: analysis of NHANES II.
        Am. J. Public Health. 1987; 77: 439-444
        • Berlin I.
        Smoking-induced metabolic disorders: a review.
        Diabetes Metab. 2008;
        • Chiolero A.
        • Faeh D.
        • Paccaud F.
        • Cornuz J.
        Consequences of smoking for body weight, body fat distribution, and insulin resistance.
        Am. J. Clin. Nutr. 2008; 87: 801-809
        • Eliasson B.
        • Attvall S.
        • Taskinen M.R.
        • Smith U.
        The insulin resistance syndrome in smokers is related to smoking habits.
        Arterioscler. Thromb. 1994; 14: 1946-1950
        • Eliasson B.
        • Mero N.
        • Taskinen M.R.
        • Smith U.
        The insulin resistance syndrome and postprandial lipid intolerance in smokers.
        Atherosclerosis. 1997; 129: 79-88
        • Eliasson B.
        • Attvall S.
        • Taskinen M.R.
        • Smith U.
        Smoking cessation improves insulin sensitivity in healthy middle-aged men.
        Eur. J. Clin. Invest. 1997; 27: 450-456
        • Balkau B.
        • Vierron E.
        • Vernay M.
        • Born C.
        • Arondel D.
        • Petrella A.
        • et al.
        The impact of 3-year changes in lifestyle habits on metabolic syndrome parameters: the D.E.S.I.R study.
        Eur. J. Cardiovasc. Prev. Rehabil. 2006; 13: 334-340
        • Davey Smith G.
        • Bracha Y.
        • Svendsen K.H.
        • Neaton J.D.
        • Haffner S.M.
        • Kuller L.H.
        Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial.
        Ann. Intern. Med. 2005; 142: 313-322
        • Persson L.G.
        • Hjalmarson A.
        Smoking cessation in patients with diabetes mellitus: results from a controlled study of an intervention programme in primary healthcare in Sweden.
        Scand. J. Prim. Health Care. 2006; 24: 75-80
        • Canga N.
        • De Irala J.
        • Vara E.
        • Duaso M.J.
        • Ferrer A.
        • Martinez-Gonzalez M.A.
        Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings.
        Diabetes Care. 2000; 23: 1455-1460
        • Sawicki P.T.
        • Didjurgeit U.
        • Muhlhauser I.
        • Berger M.
        Behaviour therapy versus doctor's anti-smoking advice in diabetic patients.
        J. Intern. Med. 1993; 234: 407-409
        • Hokanson J.M.
        • Anderson R.L.
        • Hennrikus D.J.
        • Lando H.A.
        • Kendall D.M.
        Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco.
        Diabetes Educ. 2006; 32: 562-570
        • Davies M.J.
        • Heller S.
        • Skinner T.C.
        • Campbell M.J.
        • Carey M.E.
        • Cradock S.
        • et al.
        Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.
        BMJ. 2008; 336: 491-495
      3. National Institute for Clinical Excellence (NICE), Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. http://www.nice.org.uk/TA039 (accessed 1.04.08).

      4. U.S. Food and Drug Administration (FDA), [email protected] http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm (accessed 1.04.08).

      5. National Institute for Clinical Excellence (NICE), Final appraisal determination: Varenicline for smoking cessation. http://guidance.nice.org.uk/page.aspx?o=431473 (accessed 1.04.08).

        • Marsh H.S.
        • Dresler C.M.
        • Choi J.H.
        • Targett D.A.
        • Gamble M.L.
        • Strahs K.R.
        Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study.
        Clin. Ther. 2005; 27: 1571-1587
      6. Zyban Prescribing Information. http://us.gsk.com/products/assets/us_zyban.pdf (accessed 1.04.08).

        • Kristensen P.L.
        • Pedersen-Bjergaard U.
        • Thorsteinsson B.
        Varenicline may trigger severe hypoglycaemia in type 1 diabetes.
        Diabetes Med. 2008;
      7. Pfizer Inc. Chantix® (varenicline) Tablets U.S. Prescribing Information. http://media.pfizer.com/files/products/uspi_chantix.pdf (accessed 27.06.08).

        • McBride C.M.
        • Emmons K.M.
        • Lipkus I.M.
        Understanding the potential of teachable moments: the case of smoking cessation.
        Health Educ. Res. 2003; 18: 156-170
        • Stacy R.D.
        • Loyd B.H.
        An investigation of beliefs about smoking among diabetes patients: information for improving cessation efforts.
        Patient Educ. Couns. 1990; 15: 181-189
        • Gill G.V.
        • Morgan C.
        • MacFarlane I.A.
        Awareness and use of smoking cessation treatments among diabetic patients.
        Diabetes Med. 2005; 22: 658-660
        • Scemama O.
        • Hamo-Tchatchouang E.
        • Le Faou A.L.
        • Altman J.J.
        Difficulties of smoking cessation in diabetic inpatients benefiting from a systematic consultation to help them to give up smoking.
        Diabetes Metab. 2006; 32: 435-441
        • Spangler J.G.
        • Summerso J.H.
        • Bell R.A.
        • Konen J.C.
        Smoking status and psychosocial variables in type 1 diabetes mellitus.
        Addict. Behav. 2001; 26: 21-29
      8. Nicorette nasal spray prescribing information. http://emc.medicines.org.uk/ (accessed 25.09.08).

      9. Nicorette inhaler prescribing information. http://emc.medicines.org.uk/ (accessed 25.09.08).

      10. Nicorette patch prescribing information. http://emc.medicines.org.uk/ (accessed 25.09.08).

      11. Nicorette gum prescribing information. http://emc.medicines.org.uk/ (accessed 25.09.08).